We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
TET2
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • TET2
PROTEIN SUMMARY GENE INFORMATION RNA DATA ANTIBODY DATA
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

TET2
Synonyms FLJ20032, KIAA1546
Gene descriptioni

Full gene name according to HGNC.

Tet methylcytosine dioxygenase 2
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Cancer-related genes
Disease related genes
Enzymes
Human disease related genes
Potential drug targets
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 4
Cytoband q24
Chromosome location (bp) 105145875 - 105279816
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

6
Ensembl ENSG00000168769 (version 109)
Entrez gene 54790
HGNC HGNC:25941
UniProt Q6N021 (UniProt - Evidence at protein level)
neXtProt NX_Q6N021
GeneCards TET2
Antibodypedia TET2 antibodies


PROTEIN FUNCTION
Protein function (UniProt)i

Useful information about the protein provided by UniProt.

Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Has a preference for 5-hydroxymethylcytosine in CpG motifs. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.... show less
Molecular function (UniProt)i

Keywords assigned by UniProt to proteins due to their particular molecular function.

Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase
Biological process (UniProt)i

Keywords assigned by UniProt to proteins because they are involved in a particular biological process.

Cell cycle
Ligand (UniProt)i

Keywords assigned by UniProt to proteins because they bind, are associated with, or whose activity is dependent of some molecule.

Iron, Metal-binding, Zinc
Gene summary (Entrez)i

Useful information about the gene from Entrez

The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]... show less
PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The Splice variant identifier links to the Ensembl website protein summary for the selected splice variant. The data in the Swissprot and TrEMBL columns links to corresponding pages in the UniProt database.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide and number of predicted transmembrane region(s) according to in-house majority decision methods based on sets of predictors are also reported.
Splice variant SwissProt TrEMBL Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
TET2-202
ENSP00000306705
ENST00000305737
Q6N021
[Direct mapping] Methylcytosine dioxygenase TET2
Show all
A0A024RDF7
[Target identity:100%; Query identity:100%] Methylcytosine dioxygenase TET
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Frameshift Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002521 [leukocyte differentiation]
GO:0003677 [DNA binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0006211 [5-methylcytosine catabolic process]
GO:0006325 [chromatin organization]
GO:0006493 [protein O-linked glycosylation]
GO:0006807 [nitrogen compound metabolic process]
GO:0007049 [cell cycle]
GO:0008198 [ferrous iron binding]
GO:0008270 [zinc ion binding]
GO:0016491 [oxidoreductase activity]
GO:0030099 [myeloid cell differentiation]
GO:0035511 [oxidative DNA demethylation]
GO:0043412 [macromolecule modification]
GO:0044238 [primary metabolic process]
GO:0044260 [cellular macromolecule metabolic process]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046872 [metal ion binding]
GO:0051213 [dioxygenase activity]
GO:0070579 [methylcytosine dioxygenase activity]
GO:0070989 [oxidative demethylation]
GO:0080111 [DNA demethylation]
Show all
1165 aa
130.3 kDa
No 0
TET2-203
ENSP00000369351
ENST00000380013
Q6N021
[Direct mapping] Methylcytosine dioxygenase TET2
Show all
A0A158SIU0
[Target identity:100%; Query identity:100%] Methylcytosine dioxygenase TET
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Frameshift Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002521 [leukocyte differentiation]
GO:0003677 [DNA binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0006211 [5-methylcytosine catabolic process]
GO:0006325 [chromatin organization]
GO:0006493 [protein O-linked glycosylation]
GO:0006807 [nitrogen compound metabolic process]
GO:0007049 [cell cycle]
GO:0008198 [ferrous iron binding]
GO:0008270 [zinc ion binding]
GO:0014070 [response to organic cyclic compound]
GO:0016491 [oxidoreductase activity]
GO:0030099 [myeloid cell differentiation]
GO:0035511 [oxidative DNA demethylation]
GO:0043412 [macromolecule modification]
GO:0044238 [primary metabolic process]
GO:0044260 [cellular macromolecule metabolic process]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046872 [metal ion binding]
GO:0051213 [dioxygenase activity]
GO:0070579 [methylcytosine dioxygenase activity]
GO:0070989 [oxidative demethylation]
GO:0080111 [DNA demethylation]
Show all
2002 aa
223.8 kDa
No 0
TET2-204
ENSP00000391448
ENST00000413648
E7EPB1
[Direct mapping] Methylcytosine dioxygenase TET
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005634 [nucleus]
GO:0006211 [5-methylcytosine catabolic process]
GO:0008270 [zinc ion binding]
GO:0016491 [oxidoreductase activity]
GO:0044260 [cellular macromolecule metabolic process]
GO:0046872 [metal ion binding]
GO:0051213 [dioxygenase activity]
GO:0070579 [methylcytosine dioxygenase activity]
GO:0080111 [DNA demethylation]
Show all
1167 aa
130.5 kDa
No 0
TET2-207
ENSP00000425443
ENST00000513237
E7EQS8
[Direct mapping] Methylcytosine dioxygenase TET
Show all
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0006211 [5-methylcytosine catabolic process]
GO:0006807 [nitrogen compound metabolic process]
GO:0008270 [zinc ion binding]
GO:0016491 [oxidoreductase activity]
GO:0043412 [macromolecule modification]
GO:0044238 [primary metabolic process]
GO:0044260 [cellular macromolecule metabolic process]
GO:0046872 [metal ion binding]
GO:0051213 [dioxygenase activity]
GO:0070579 [methylcytosine dioxygenase activity]
GO:0080111 [DNA demethylation]
Show all
2023 aa
226.1 kDa
No 0
TET2-208
ENSP00000426885
ENST00000514870
D6RE87
[Direct mapping] Methylcytosine dioxygenase TET
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Frameshift Mutations
Human disease related genes
   Cancers
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005634 [nucleus]
GO:0006211 [5-methylcytosine catabolic process]
GO:0008270 [zinc ion binding]
GO:0016491 [oxidoreductase activity]
GO:0044260 [cellular macromolecule metabolic process]
GO:0046872 [metal ion binding]
GO:0051213 [dioxygenase activity]
GO:0070579 [methylcytosine dioxygenase activity]
GO:0080111 [DNA demethylation]
Show all
110 aa
12.2 kDa
No 0
TET2-209
ENSP00000442788
ENST00000540549
Q6N021
[Direct mapping] Methylcytosine dioxygenase TET2
Show all
A0A158SIU0
[Target identity:100%; Query identity:100%] Methylcytosine dioxygenase TET
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
   THUMBUP predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
   COSMIC Frameshift Mutations
Disease related genes
Potential drug targets
Human disease related genes
   Cancers
   Cancers of haematopoietic and lymphoid tissues
   Cardiovascular diseases
   Hematologic diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002521 [leukocyte differentiation]
GO:0003677 [DNA binding]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0006211 [5-methylcytosine catabolic process]
GO:0006325 [chromatin organization]
GO:0006493 [protein O-linked glycosylation]
GO:0006807 [nitrogen compound metabolic process]
GO:0007049 [cell cycle]
GO:0008198 [ferrous iron binding]
GO:0008270 [zinc ion binding]
GO:0016491 [oxidoreductase activity]
GO:0030099 [myeloid cell differentiation]
GO:0035511 [oxidative DNA demethylation]
GO:0043412 [macromolecule modification]
GO:0044238 [primary metabolic process]
GO:0044260 [cellular macromolecule metabolic process]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046872 [metal ion binding]
GO:0051213 [dioxygenase activity]
GO:0070579 [methylcytosine dioxygenase activity]
GO:0070989 [oxidative demethylation]
GO:0080111 [DNA demethylation]
Show all
2002 aa
223.8 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org